Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1

Interventions

Oxaliplatin 81S 1 (combination) 55Capecitabine 44apatinib 32Paclitaxel 32Docetaxel 32Irinotecan 27Fluorouracil 22Drug Therapy 21sintilimab 20Cisplatin 20Leucovorin 16Hyperthermic Intraperitoneal Chemotherapy 13XELOX 12Surgical Procedures, Operative 12camrelizumab 10Trastuzumab 10titanium silicide 9pembrolizumab 9Tegafur 9Nivolumab 9Neoadjuvant Therapy 9Laparoscopy 8Gastrectomy 8Ramucirumab 7Folfox protocol 7Chemotherapy, Adjuvant 7toripalimab 6tislelizumab 6Gastroscopy 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Stomach Neoplasms × bismuth tripotassium dicitrate × Clear all
NCT06216639 2024-02-09

Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection

National Institute of Public Health, Slovenia

Unknown
2,000 enrolled
Gastrointestinal

Stomach Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡